Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
Tag: personalized medicine
Bio-IT World Review: BIG Data; BIG Promise; BIG CHALLENGES.
New Cambridge Observer’s Anita Harris on BIO-IT World 2012, describing the promise and problems presented by burgeoning of health care data.
Scientia Advisors Presents Webinars on Medical Industries
Scientia Advisors is offering five free Webinars for anyone interested in trends in the health care and life science industries.
New personalized medicine model could lead to better care, lower costs, higher profits
Cambridge consulting firm Scientia Advisors says that big pharma could begin to reap profits from personalized medicine much sooner than predicted by marketing new diagnostics tools along with drugs that are already on the market. (Most pharma companies are currently…
